Company intelligence / Profile preview

YAZIO

Ownership: Private
Employees: ~85
Development stage: Commercial

Overview

YAZIO offers a leading nutrition and calorie tracking app with millions of users in over 150 countries. The platform provides calorie counting, macronutrient analysis, intermittent fasting tools, recipe databases, activity tracking integration, and personalized meal planning. It is designed to support weight loss, muscle gain, and healthier eating habits but does not develop or market pharmaceutical or biotech products.

Therapeutic areas: Metabolic DisordersEndocrinologyMen's Health
Modalities: Non-pharmacological therapy (digital health app for nutrition, weight management, and lifestyle)
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

No major pharmaceutical or biotech partnerships reported; possible collaborations with fitness wearable manufacturers for data integration.

Beyond the preview

Go deeper on YAZIO.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on YAZIO.

Explore the full profile